🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Incidence of 107 Lymph Node Metastasis

Recruitingn/aAges 20 Years - 85 YearsAllFudan University
NCT07165184 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

the study was to document the incidence o subcarinal lymph node metastasis, and the risk factors of metastasis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients with esophageal squamous cell carcinoma * clinical staging: cT1-4a N0/+ M0. * no history of other malignancy. Exclusion Criteria: * esophageal cancer in the neck * poor physical status to have esophagectomy.
💊

What it tests

  • no intervention was applied as observation study
📍

Where

1 site
Fudan University Shanghai Cancer Center
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy